MCAL Therapeutics Inc. — Form D
MCAL Therapeutics Inc. of PARK CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-27. The offering totals $5.9M, of which $5.9M was reported sold. Industry: Other.
Offering
- Filed: 2024-03-27
- Form: D
- Accession: 0001812100-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $5.9M
- Amount sold: $5.9M
- Investors: 29
- Date of first sale: 2024-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508812
Issuer
- Name: MCAL Therapeutics Inc.
- CIK: 0001812100
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 291 Daly Ave, PARK CITY, UT, 84060
- Phone: (510) 914-1896
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Dan J Albert | Director | Park City, UT |
| Tom Gadek | Director | Park City, UT |
| Tom J Mather | Director | Park City, UT |
| Chris J Murphy | Director | Park City, UT |
| Charles O'Neill | Director | Park City, UT |
| Tom Gadek | Executive Officer | Park City, UT |
| Charles O'Neill | Executive Officer | Park City, UT |
| Thomas Gadek | Director | Charlottesville, VA |
| Thomas Gadek | Executive Officer | Charlottesville, VA |
| Tanya Shnaydman | Executive Officer | Park City, UT |
| Christopher J Murphy | Director | Madison, WI |
Other filings by this issuer (1)
More